i figure a small parcel making up 1-2% of my portfolio its a good punt:
- its got a beaten down sp
- a positive catalyst due shortly in the ce mark
- genuinely innovative product in an area of need
- good preliminary data
- phase 2 studies starting shortly
- strong institutional affiliations in usa/ uk
worse case scenario, it doesnt get the ce mark yet and drops a few more cents
best case, its the next sirtex (long shot but not out of the question) or a takeover target for a bigger biotech/ pharma
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
0.210(20.6%) |
Mkt cap ! $17.49M | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.24 | $1.03 | $200.2K | 169.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 60000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |